La vendita allo scoperto per Bexil Investment Trust dà agli investitori un'idea del grado in cui gli investitori stanno scommettendo sul declino delle azioni di Bexil Investment Trust. I dati relativi alle vendite allo scoperto vengono aggiornati ogni due settimane.

Bexil Investment Trust (OTC:BXSY) Azioni, Report sulle vendite allo scoperto

Bexil Investment Trust is a diversified, closed-ended management investment company. The fund's investment objective is to seek high current income with a secondary objective of capital appreciation. The fund seeks to invest in stocks of companies operating across diversified sectors. It mainly invests in dividend-paying stocks of companies across all capitalizations. The Fund seeks to achieve its objectives by investing, under normal circumstances, in income-generating equity securities, including dividend-paying common stocks, convertible securities, preferred stocks, securities of registered investment companies, exchange-traded funds organized as investment companies or otherwise, real estate investment trusts, depositary receipts, and other equity-related securities.

Bexil Investment Trust

Highlights of the REZILIENT1 Phase 1/2 trial in the authors' conclusions include:
<ul>
<li>Zipalertinib demonstrated clinically meaningful efficacy in the primary efficacy population (n=176), including 51 patients who had received prior amivantamab.</li>
<li>The confirmed objective response rate (ORR) was 35.2% overall, and median duration of response (mDOR) and progression-free survival were 8.8 months and 9.4 months, respectively.</li>
<li>In patients treated after prior platinum-based chemotherapy only (n=125), ORR was 40% with mDOR of 8.8 months.</li>
<li>The safety profile of zipalertinib was manageable and consistent with previously reported data.¹</li>
<li>In exploratory subgroup analyses:
<ul>
<li>Patients who had received prior&nbsp;amivantamab without other ex20ins-targeted therapy showed a confirmed ORR of 30% and mDOR of 14.7 months.</li>
<li>Patients with brain metastases showed a confirmed&nbsp;ORR of 30.9% and a mDOR of 8.3 months</li>
</ul>
</li>
</ul>

News

CGEM

TAIHF

Reported Sunday, Taiho And Cullinan's Zipalertinib Shows 40% ORR In Platinum-Treated EGFR ex20ins NSCLC, REZILIENT1 Results Published In JCO

Reported Saturday, Tempus Unveils Fuses Program To Transform Precision Medicine With AI-Powered Diagnostic Models And Multimodal Data At Scale

<ul>
<li>TROPION-Lung02 and TROPION-Lung04 phase 1b results support combination of Daiichi Sankyo and AstraZeneca's DATROWAY with immunotherapy as first-line treatment for advanced or metastatic NSCLC</li>
<li>TROPION-Lung02 results include first exploratory QCS analysis of DATROWAY in first-line setting</li>
<li>NeoCOAST-2 phase 2 results continue to show potential for DATROWAY plus durvalumab and single-agent platinum chemotherapy in neoadjuvant setting</li>
</ul>

DSNKY

Reported Sunday, AstraZeneca's DATROWAY Shows Over 55% Response Rate In First-Line Advanced NSCLC In TROPION-Lung02 Phase 1b Trial With Immunotherapy Combinations

<ul>
<li>Two-thirds (67.4%) of patients treated with IMFINZI-based perioperative regimen remained event-free at two years</li>
<li>First and only immunotherapy to demonstrate statistically significant event-free survival in a global Phase III trial in this setting</li>
</ul>

Reported Sunday, AstraZeneca's IMFINZI Regimen Reduces Risk Of Progression, Recurrence, Or Death By 29% In Early Gastric Cancer In Phase 3 MATTERHORN Trial

First pivotal trial to demonstrate clinical value of monitoring circulating tumor DNA to detect and treat emerging resistance in 1st-line therapy ahead of disease progression in breast cancer
First and only next-generation oral SERD and complete ER antagonist to demonstrate consistent progression-free survival benefit in combination with widely approved CDK4/6 inhibitors in 1st-line advanced breast cancer

Reported Sunday, AstraZeneca's Camizestrant Reduces Risk Of Progression Or Death By 56% In HR+ Advanced Breast Cancer With ESR1 Mutation In SERENA-6 Trial

Campbell's Company (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CPB#NASDAQ">CPB</a>) will release its third-quarter earnings results before the opening bell on <a href="https://www.benzinga.com/quote/cpb/earnings">Monday, June 2.</a>
Analysts expect the Camden, New Jersey-based company to report quarterly earnings at 66 cents per share, down from 75 cents per share in the year-ago period. Campbell's projects to report quarterly revenue of $2.43 billion. Compare that to the $2.37 billion it reported last year, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
On March 5, the company reported second-quarter sales growth of 9% to $2.685 billion, missing the analyst consensus estimate of $2.74 billion.
Campbell's shares fell 0.4% to close at $34.04 on Friday.
Benzinga readers can access the latest analyst ratings on the <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">Analyst Stock Ratings</a> page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Let's have a look at how Benzinga's most-accurate <a href="https://www.benzinga.com/quote/cpb/analyst-ratings">analysts have rated the company</a> in the recent period.
<ul class="wp-block-list">
<li>Wells Fargo analyst Chris Carey maintained an Equal-Weight rating and slashed the price target from $40 to $34 on May 30, 2025. This analyst has an accuracy rate of 63%.</li>
<li>Piper Sandler analyst Michael Lavery maintained an Overweight rating and cut the price target from $45 to $42 on May 23, 2025. This analyst has an accuracy rate of 66%.</li>
<li>Morgan Stanley analyst Megan Alexander initiated coverage on the stock with an Equal-Weight rating and a price target of $40 on March 24, 2025. This analyst has an accuracy rate of 70%.</li>
<li>JP Morgan analyst Ken Goldman downgraded the stock from Overweight to Neutral and cut the price target from $48 to $37 on March 6, 2025. This analyst has an accuracy rate of 78%.</li>
<li>Jefferies analyst Rob Dickerson maintained a Hold rating and slashed the price target from $42 to $40 on March 5, 2025. This analyst has an accuracy rate of 66%</li>
</ul>
Considering buying CPB stock? Here&#8217;s what analysts think:
Read This Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/cannabis/25/05/45692676/wall-streets-most-accurate-analysts-spotlight-on-3-utilities-stocks-delivering-high-dividend-yields-8">Wall Street&#8217;s Most Accurate Analysts Spotlight On 3 Utilities Stocks Delivering High-Dividend Yields</a> </li>
</ul>
Photo via Shutterstock

Earnings

Price Target

Pre-Market Outlook

Markets

Analyst Ratings

Trading Ideas

Top Wall Street Forecasters Revamp Campbell's Expectations Ahead Of Q3 Earnings

<ul>
<li>Daiichi Sankyo and AstraZeneca's ENHERTU demonstrated a median overall survival of 14.7 months</li>
<li>Results reinforce second-line use of ENHERTU globally in this setting</li>
</ul>

Reported Saturday, Daiichi Sankyo And AstraZeneca's ENHERTU Demonstrates 14.7-Month Median OS And 30% Reduction In Risk Of Death In HER2+ Gastric Cancer

New five-year agreement delivers critical academic and life sciences insights into more than 400 institutions, broadening access and driving national research excellence

CLVT

Clarivate And CAPES Sign Five-Year Agreement To Broaden Access To Trusted Academic And Life Sciences Tools Across Brazil

On Sunday, Sen. Elizabeth Warren (D-Mass.) doubled down on her accusations that Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) CEO Elon Musk benefited from Donald Trump's <a href="https://www.benzinga.com/25/03/44183216/elizabeth-warren-wants-to-know-from-elon-musk-mark-zuckerberg-and-jeff-bezos-how-much-they-spent-lobbying-for-potential-windfall-accuses-tech-giants-of-cozying-up-up-to-trump-admini">sweeping tariffs</a>, calling for a federal investigation into what she labeled "textbook corruption."
What Happened: In a video posted on social media, Warren alleged that Starlink, Musk's satellite internet venture, received favorable foreign operating permits around the same time Trump imposed broad tariffs during trade negotiations.
"Suddenly, some of the same countries that were negotiating trade deals with Trump started giving Starlink some pretty good deals," Warren said, citing <a href="https://www.benzinga.com/news/global/25/05/45537805/musks-starlink-could-sidestep-south-african-equity-rules-under-deal-aimed-at-calming-relations-ahead-of-trump-meeting-report">new Starlink permits</a> in Gambia, Bangladesh, Vietnam and India.
See Also:&nbsp;<a href="https://www.benzinga.com/media/25/05/45664231/teslas-optimus-may-be-the-first-humanoid-robot-to-achieve-high-volume-and-tech-scale-says-nvidia-ceo-jensen-huang-likely-to-be-the-next-multi-trillion-dollar-industry" target="_blank" rel="noreferrer noopener">Tesla&#8217;s Optimus May Be The First Humanoid Robot To Achieve High Volume And Tech Scale, Says Nvidia CEO Jensen Huang: ‘… Likely To Be The Next Multi-Trillion Dollar Industry&#8217;</a>
"Is Elon Musk using international trade negotiations as leverage to make even more and more and more money for himself?" she asked. "Looks like textbook corruption."
Warren warned that &#8220;Elon Musk is cashing in on Donald Trump&#8217;s tariffs,&#8221; while everyone else is paying for this chaos, referring to the consumer impact of higher import prices.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Did Elon Musk use Trump's tariffs as leverage to make more and more money for himself?   I called for an investigation, because while Elon is cashing in, everyone else is paying for this chaos. We all deserve answers. <a href="https://t.co/4cKv0f3VCJ">pic.twitter.com/4cKv0f3VCJ</a>
&mdash; Elizabeth Warren (@SenWarren) <a href="https://twitter.com/SenWarren/status/1929230259246834061?ref_src=twsrc%5Etfw">June 1, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
SpaceX did not immediately respond to <a href="https://pro.benzinga.com/dashboard">Benzinga's</a> request for comments.
Why It's Important: Last month, Senate Democrats, including Warren, urged a federal <a href="https://www.benzinga.com/general/space/25/05/45430526/as-elon-musk-secures-saudi-starlink-deal-elizabeth-warren-and-senate-democrats-demand-probe-into-possible-ethics-violations-and-accuse-trump-administration-of-helping-spacex-secure-foreign-deals">probe into whether</a> Trump's administration is helping SpaceX gain entry into international markets.
This demand followed Musk's announcement at the Saudi-U.S. Investment Forum that Saudi Arabia has authorized Starlink services for use in the aviation and maritime sectors.
Previously, The Washington Post reported that state department cables showed that U.S. embassies and the department consistently encouraged tariff-affected <a href="https://www.benzinga.com/tech/25/05/45316049/us-reportedly-pressures-tariff-hit-nations-to-approve-elon-musks-starlink-an-important-lubricant-that-facilitates-a-deal">countries to ease restrictions</a> on satellite firms, often highlighting Starlink by name.
In April, senate democratic committee staffers released a report alleging that Musk could <a href="https://www.benzinga.com/25/04/45058801/elon-musks-doge-influence-could-help-his-companies-avoid-over-2-billion-in-potential-liabilities-senate-report">potentially bypass over $2 billion</a> in financial obligations due to his sway within the U.S. government.
Price Action: Tesla stock dropped 3.34% on Friday, finishing the day at $346.46. It slipped a further 0.27% in after-hours trading. So far this year, the stock is down 8.65%, based on <a href="http://pro.benzinga.com/">Benzinga Pro data</a>.
According to Benzinga Edge Stock Rankings, Tesla holds an impressive growth score of 91.89%. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound">Click here to see how it measures up against other top-performing stocks</a>.
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound"><img decoding="async" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/02024321/Screenshot-2025-06-02-at-9.59.43%E2%80%AFAM-1.png" alt="" class="wp-image-934603" /></a></figure>
Photo: Shutterstock/Sheila Fitzgerald
Read Next:&nbsp;
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/25/05/45396297/cathie-wood-dumps-palantir-as-stock-touches-peak-prices-bails-on-soaring-flying-taxi-maker-archer-aviation" target="_blank" rel="noreferrer noopener">Cathie Wood Dumps Palantir As Stock Touches Peak Prices, Bails On Soaring Flying-Taxi Maker Archer Aviation</a></li>
</ul>
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Government

Tech

TSLA

Elizabeth Warren Calls It 'Textbook Corruption,' Once Again Asks For Probe Into Elon Musk 'Cashing In' On Trump Tariffs

Colt, Honeywell and Nokia join forces to trial space-based quantum-safe cryptography
<ul>
<li>Tech collaboration will explore ways to protect encrypted data from quantum risk using Low Earth Orbit satellites.</li>
<li>Trial to use space-based quantum key distribution to overcome terrestrial distance limitations.</li>
</ul>

CZGZF

Colt, Honeywell, And Nokia Collaborate On Space-Based Quantum-Safe Cryptography Using Low Earth Orbit Satellites

<ul>
<li>MaxLinear G.hn Technology enables Comtrend's powerline data modules to accelerate EV charger installations</li>
</ul>

MaxLinear And Comtrend Unveil EV Charging Station Modules Using G.hn For Real-Time, Reliable Data Over Existing Powerlines

<ul>
<li>RP1 plus nivolumab generated robust responses in both injected and non-injected lesions.</li>
<li>Deep/visceral injections, including into the liver and lung, resulted in numerically higher rates of response compared to superficial injections only and were generally well tolerated.</li>
</ul>

REPL

Reported Sunday, Replimune Reports 32.9% ORR With RP1 Plus Nivolumab In Anti-PD1 Failed Melanoma At ASCO, With Deep Organ Injections Showing Higher Response Rates

Strategy Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSTR#NASDAQ">MSTR</a>) executive chairman Michael Saylor expressed interest Saturday in discussing Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) with popular podcaster Joe Rogan.
What Happened:&nbsp;In an X post, Saylor wrote, &#8220;Hey Joe Rogan, let&#8217;s talk about Bitcoin.&#8221;
The comment came in response to a fan-run account&#8217;s question to X users about who they&#8217;d like to see Rogan interview that he hasn&#8217;t before.
Rogan, one of the world&#8217;s most successful podcasters, has interviewed influential figures like tech mogul&nbsp;Elon Musk, boxing legend&nbsp;Mike Tyson and President&nbsp;Donald Trump on his "The Joe Rogan Experience" show. As of this writing, his YouTube channel has nearly 20 million subscribers.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Hey <a href="https://twitter.com/joerogan?ref_src=twsrc%5Etfw">@JoeRogan</a>, let&#39;s talk about Bitcoin.
&mdash; Michael Saylor (@saylor) <a href="https://twitter.com/saylor/status/1928931268852412704?ref_src=twsrc%5Etfw">May 31, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
In other news, Saylor hinted on X that his firm Strategy would continue to pile on BTC in the coming week. 
&#8220;Orange is my Preferred Color,&#8221; he wrote,<a href="https://www.benzinga.com/markets/cryptocurrency/25/05/45188974/michael-saylor-hints-more-btc-purchases-on-the-way-as-mstr-surges-47-in-a-month-too-much-blue-not-enough-orange"> typical of his Sunday posts</a> which have almost always preceded Bitcoin purchases the following Monday.
As of this writing, Strategy's Bitcoin stockpile has grown to 580,250 BTC, worth nearly $61 billion, with an unrealized profit of 50%,&nbsp;<a href="https://bitcointreasuries.net/" target="_blank" rel="noreferrer noopener">according&nbsp;</a>to&nbsp;&nbsp;bitcointreasuries.com.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Orange is my Preferred Color <a href="https://t.co/rc9JIcJOAT">pic.twitter.com/rc9JIcJOAT</a>
&mdash; Michael Saylor (@saylor) <a href="https://twitter.com/saylor/status/1929152786186301755?ref_src=twsrc%5Etfw">June 1, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
See Also:&nbsp;<a href="https://benzinga.com/cannabis/25/06/45713578/jerome-powell-to-step-down-x-abuzz-with-rumors-but-polymarket-bettors-are-not-buying-it" target="_blank" rel="noreferrer noopener">Jerome Powell To Step Down? X Abuzz With Rumors, But Polymarket Bettors Are Not Buying It</a>
Why It Matters:&nbsp;The proposed discussion holds significance in light of Rogan&#8217;s known interest in Bitcoin. The podcast host has previously <a href="https://www.benzinga.com/markets/cryptocurrency/23/10/35139978/joe-rogan-tells-sam-altman-that-bitcoin-can-become-a-universal-viable-currency-admits-cbdc" target="_blank" rel="noreferrer noopener">called Bitcoin the &#8220;real fascinating cryptocurrency</a>&#8221; and one with the most likelihood of becoming a &#8220;universal viable currency.&#8221;
In fact, back in April 2014, <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42229486/joe-rogans-bitcoin-pile-has-grown-over-30000-in-value-but-he-hasnt-sold-conviction-based-hodling-or-has-the-podcast-king-lost-his-keys">Rogan publicly shared details</a> of his Bitcoin address, which as of this writing has a balance of 5.243 BTC, translating to $550,362.
Price Action:&nbsp; At the time of writing, Bitcoin was exchanging hands at $104,971, up 0.52% in the last 24 hours, according to&nbsp;<a href="https://pro.benzinga.com/dashboard?_gl=1&#x2A;380nj0&#x2A;_ga&#x2A;MTEyOTAyOTcxMy4xNzEzMzY0NTYy&#x2A;_ga_V7ZK73W7N0&#x2A;MTcxNDk4MzIzMi42LjEuMTcxNDk4OTE0Ni4wLjAuMA.." target="_blank" rel="noreferrer noopener">data from Benzinga Pro</a>.&nbsp;
Shares of Strategy closed 0.39% closer at $369.20 during Friday&#8217;s regular session. The stock has returned over 27% year-to-date.
MSTR exhibited a very high momentum score—a measure of the stock&#8217;s relative strength based on its price movement patterns and volatility over multiple timeframes—as of this writing. Visit <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound" target="_blank" rel="noreferrer noopener">Benzinga Edge Stock Rankings</a>. to view the top ten stocks with the highest momentum scores.
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound"><img loading="lazy" decoding="async" width="517" height="200" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/02024043/Screenshot-2025-06-02-121027.png" alt="" class="wp-image-934601" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/02024043/Screenshot-2025-06-02-121027.png 517w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/02024043/Screenshot-2025-06-02-121027-300x116.png 300w" sizes="(max-width: 517px) 100vw, 517px" /></a></figure>
Photo Courtesy: Rokas Tenys on Shutterstock.com
Read Next:&nbsp;
<ul class="wp-block-list">
<li><a href="https://benzinga.com/crypto/cryptocurrency/25/06/45712312/michael-saylor-called-scaramucci-from-a-yacht-and-it-changed-the-ending-of-his-book" target="_blank" rel="noreferrer noopener">Michael Saylor Called Scaramucci From a Yacht and It Changed the Ending of His Book</a></li>
</ul>
Disclaimer:&nbsp;This content was partially produced with the help of&nbsp;<a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a>&nbsp;and was reviewed and published by Benzinga editors.<a href="https://www.benzinga.com/apis?utm_source=benzinga.com&amp;utm_campaign=article-bottom" rel="noreferrer noopener" target="_blank"></a>

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

MSTR

Michael Saylor Asks Joe Rogan For A Chat: 'Let's Talk About Bitcoin'

<ul>
<li>Data Highlights Transformative Promise of CAR T in Solid Tumors</li>
<li>Phase 1 Trial with ALLO-316 Demonstrated Potential to Provide Meaningful Clinical Benefit in Patients with CD70 TPS ≥ 50% Advanced or Metastatic RCC
<ul>
<li>A Single Dose of ALLO-316 Achieved a 31% Confirmed Response Rate</li>
<li>Four of Five Confirmed Responders Remain in Response Including One Ongoing Remission Over 12 Months</li>
</ul>
</li>
<li>Robust Expansion, Persistence, and Tumor Infiltration of ALLO-316 Seen with Standard Lymphodepletion, Showcasing Dagger&#xAE; Technology as a Next-Generation Allogeneic Platform</li>
<li>Phase 1 Safety Profile was Manageable; Proactive Diagnostic and Management Strategies Proved Effective in Mitigating IEC-HS While Preserving Efficacy</li>
</ul>

ALLO

Reported Sunday, Allogene Reports 31% Confirmed Response Rate With ALLO-316 In CD70-High RCC Patients At ASCO, With Durable Remissions And Manageable Safety

Chinese EV giant BYD Co. Ltd. (OTC:<a class="ticker" href="https://www.benzinga.com/stock/BYDDY#OTC">BYDDY</a>) (OTC:<a class="ticker" href="https://www.benzinga.com/stock/BYDDF#OTC">BYDDF</a>) is reportedly facing backlash for its aggressive discounts that have triggered a price war in the fiercely contested EV market in China.
What Happened: BYD's stock fell over 5% on the Hong Kong exchange following last week's 15% plunge, due to reports that the price war had caught Beijing's attention, Bloomberg reported <a href="https://www.bloomberg.com/news/articles/2025-06-01/byd-may-sales-highest-this-year-after-week-of-steep-discounts">on</a> Sunday.
The Chinese Communist Party&#8217;s (CCP) newspaper, The People's Daily, slammed the "rat race" in the domestic EV sector, which it said could hurt domestic supply chains and damage the "Made in China" reputation. However, it did not name any specific companies, the report said.
The report also mentioned that China's automobile association criticized the price war, which could impact the sector's growth and bring about quality issues, while China's Ministry of Industry and Information Technology agreed with the stance.
Why It Matters: The news comes in as China's EV price war has led to an intense competition in the country among EV manufacturers offering <a href="https://www.benzinga.com/25/01/42761825/ev-price-war-heats-up-as-chinese-automakers-extend-subsidies">aggressive discounts</a> to drive up sales.
Interestingly, BYD and other Chinese players are bolstering their presence in markets outside of China, with BYD already surpassing Elon Musk's Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) <a href="https://www.benzinga.com/25/05/45564693/byd-outsells-elon-musks-tesla-amid-european-plans-shift-into-gear">in European sales </a>as the company is offering the Euro-spec version of its <a href="https://www.benzinga.com/markets/25/05/45560953/byds-europe-pivot-in-full-swing-with-new-26000-affordable-ev-amid-tesla-sal">best-selling EV hatchback</a> in the region for $26,000.
On the flip side, a major BYD dealer in China has reportedly <a href="https://www.benzinga.com/25/05/45666513/a-major-byd-dealer-in-china-shut-down-its-operations-as-ev-giant-expands-into-europe-report">closed down over 20 dealerships </a>in the country across 4 major cities, citing what the dealer said were policy changes by the automaker that impacted the company's cash flow.
Elsewhere, experts like Future Fund LLC's Gary Black indicate that BYD's price war <a href="https://www.benzinga.com/general/travel/25/05/45611551/gary-black-says-price-war-by-byd-threatens-tesla-dismisses-elon-musks-comeback-as-non-event">could threaten Tesla's position</a> in the country.
Check out more of Benzinga's Future Of Mobility coverage by<a href="https://www.benzinga.com/topic/mobility"> following this link</a>.&nbsp;
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/government/regulations/25/05/45639357/teslas-chinese-rival-byd-sued-for-45-million-over-alleged-human-trafficking-slave-like-conditions-at-brazil-factory-site">Tesla&#8217;s Chinese Rival BYD Sued For $45 Million Over Alleged Human Trafficking, Slave-Like Conditions At Brazil Factory Site</a></li>
</ul>
Photo courtesy: Tada Images / Shutterstock.com

BYDDF

BYDDY

BYD's Aggressive Pricing Triggers EV 'Rat Race:' Stock Tumbles, Authorities Voice Concern

<ul>
<li>Treatment with casdatifan, a HIF-2a inhibitor, plus cabozantinib, a tyrosine kinase inhibitor, showed a confirmed overall response rate (ORR) of 46% in patients who reached a minimum of 12 weeks (two scans) of follow-up</li>
<li>The combination had a manageable safety profile, and there was no meaningful overlapping toxicity for the two drugs</li>
<li>These data support the initiation of PEAK-1, a Phase 3 study that will evaluate casdatifan plus cabozantinib in immunotherapy-experienced clear cell renal cell carcinoma (ccRCC) patients, and eVOLVE-RCC02, a Phase 1b/3 study in first-line ccRCC patients, both of which will begin shortly</li>
<li>Arcus will host a conference call to discuss these data at 5:00 AM PT / 7:00 AM CT on Monday, June 2, 2025</li>
</ul>

RCUS

Reported Sunday, Arcus ARC-20 Data Show 46% Confirmed Response Rate With Casdatifan And Cabozantinib In Immunotherapy-Experienced Kidney Cancer

German cognitive scientist Joscha Bach says humanity faces a bigger existential threat from dragging its feet on artificial intelligence than from building it too fast.
What Happened: Speaking last week at the California Institute for Machine Consciousness, the longtime AI theorist argued that climate change, super-volcanoes and our own "inability to stay aligned with survival" pose a higher kill-shot probability than a runaway algorithm — unless people use the current "technological bubble" to build smarter machines fast.
"Over a long enough time span, it&#8217;s certain something will lead to our extinction … I'm much more afraid that we don't build AI than that we build it," he told the audience.
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="CIMC Machine Consciousness Salon: Existential Hope (Joscha Bach, Lou de K)" width="500" height="281" src="https://www.youtube.com/embed/VDhan5Kd3ms?feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
Bach, who researches machine consciousness and computational models of mind, has previously written that society must "make AI beautiful" — safe, aligned systems capable of steering civilisation through the next evolutionary bottleneck.
Without AI, Bach argues, civilization's respite from predators and famine is a temporary "bubble" that will burst. Scaling intelligent machines, he says, is the only credible way to invent planetary-scale defenses.
See also: <a href="https://www.benzinga.com/markets/macro-economic-events/25/06/45714416/former-treasury-secretary-larry-summers-warns-the-dollar-is-starting-to-trade-like-a-latin-american-currency-greenback-going-from-safe-haven-to-risk-asset">Former Treasury Secretary Larry Summers Warns The Dollar Is Starting To Trade Like A Latin American Currency — Greenback Going From Safe Haven To Risk Asset?</a>
Why It Matters: The plea drops into a rift among AI luminaries. OpenAI chief Sam Altman <a href="https://www.benzinga.com/media/25/05/45312650/sam-altman-tells-congress-us-must-pursue-sensible-regulation-avoid-silly-mistake-to-stay-ahead-of-china-in-ai-race-its-hard-to-say-how-far-ahead-we-are">has shifted</a> from calling for sweeping guardrails in 2023 to urging "sensible regulation&#8221; that &#8220;does not slow us down," framing speed as vital to out-innovate China. Elon Musk and Apple (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) co-founder Steve Wozniak <a href="https://www.benzinga.com/news/23/03/31543935/elon-musk-steve-wozniak-pinterest-founder-sign-open-letter-to-pause-trials-of-ai-more-powerful-than">joined a 2024 open letter</a> demanding a six-month moratorium on systems beyond GPT-4, though Musk <a href="https://www.benzinga.com/news/24/03/37987626/is-superintelligence-safe-elon-musk-backtracks-on-ai-warnings?utm_source=chatgpt.com">later called the effort</a> "futile."
Geoffrey Hinton, the "Godfather of AI," quit Google (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>) in 2023 after concluding there is a <a href="https://www.benzinga.com/news/24/06/39319028/terminator-in-real-life-ai-godfather-warns-of-human-wipe-out-in-5-to-20-years">50-50 chance</a> advanced systems could wipe out humanity within two decades. At Davos, fellow Turing Award winner Yoshua Bengio <a href="https://www.businessinsider.com/yoshua-bengio-ai-godfather-agents-2025-1">told</a> Business Insider that autonomous "agentic" models could be the most dangerous route and pushed for international safety rules before such systems scale.
Meta's (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) Yann LeCun, in an <a href="https://www.wired.com/story/artificial-intelligence-meta-yann-lecun-interview/">interview</a> with WIRED, dismisses such doomsday talk as "stupid," insisting today's models still lack basic reasoning and common sense.
Photo Courtesy: Tapati Rinchumrus on Shutterstock.com
Read next: <a href="https://www.benzinga.com/cannabis/25/06/45714519/ross-ulbricht-the-silk-road-founder-pardoned-by-trump-soon-after-his-inauguration-receives-a-whopping-31-million-worth-of-bitcoin-in-donation-wallet">Ross Ulbricht, The Silk Road Founder Pardoned By Trump Soon After His Inauguration, Receives A Whopping $31 Million Worth Of Bitcoin In Donation Wallet</a>

AAPL

GOOG

GOOGL

Delaying Artificial Intelligence The Real Existential Risk Says Joscha Bach, Scientist Says He's More Afraid That 'We Don't Build AI'

Federal Reserve Governor Christopher Waller warned that tariff-induced inflation could temporarily push prices higher while signaling potential rate cuts later in 2025, contingent on trade policy clarity and economic stability.
What Happened: Speaking at the Bank of Korea International Conference in Seoul on Sunday, Waller outlined two tariff scenarios that could drive inflation to peaks between 3-5% this year. His base case now assumes a 15% trade-weighted tariff on U.S. goods imports, falling between his previously modeled large and smaller tariff scenarios.
The governor&#8217;s cautious stance comes as President Donald Trump recently summoned Fed Chair Jerome Powell to the White House, telling him he was &#8220;making a mistake&#8221; by not cutting rates. The Federal Reserve Board maintained rates at 4.25%-4.50% for the third consecutive meeting, with officials <a href="https://www.benzinga.com/news/politics/25/05/45692797/trump-tells-powell-hes-making-a-mistake-by-not-cutting-rates-fed-reaffirms-independence">citing increased economic uncertainty</a>.
The Fed governor dismissed concerns about inflation persistence, citing key differences from the 2021-2022 period. Unlike the pandemic era&#8217;s labor shortages, supply chain disruptions, and massive fiscal stimulus, current conditions show no labor shortage and limited supply chain stress. Monetary policy also differs significantly, with the Fed maintaining rates above 4% versus near-zero during the pandemic.
See Also: <a href="https://www.benzinga.com/cannabis/25/06/45713895/bitcoin-ethereum-dogecoin-hold-steady-amid-us-china-trade-war-tensions-analyst-foresees-big-party-if-btc-reclaims-106000">Bitcoin, Ethereum, Dogecoin Hold Steady Amid US-China Trade War Tensions: Analyst Foresees &#8216;Big Party&#8217; If BTC Reclaims $106,000</a>
Why It Matters: Waller highlighted diverging inflation expectations between households and financial markets. University of Michigan consumer surveys show near-term expectations at 6.6% and longer-term at 4.2%, while Treasury Inflation-Protected Securities compensation remains around 2.4-2.7%.
Financial markets currently price <a href="https://www.benzinga.com/markets/25/05/45610672/market-is-risk-off-chamath-palihapitiya-flags-rising-investor-fear-as-money-market-fund-assets-hit-724-trillion">rate cuts beginning in September</a>, with billionaire investor Chamath Palihapitiya flagging rising investor caution as money market fund assets hit $7.24 trillion. JPMorgan Chase &amp; Co. CEO Jamie Dimon recently warned of stagflation risks amid <a href="https://www.benzinga.com/government/regulations/25/05/45561399/jamie-dimon-says-us-is-not-in-a-sweet-spot-flags-stagflation-risk-and-deficit-problems-amid-trump-china-tensions">deficit concerns and geopolitical tensions</a>.
Waller concluded that assuming tariff rates settle near his lower scenario and underlying inflation progresses toward the Fed&#8217;s 2% target, he would support &#8220;good news&#8221; rate cuts later this year. The stance reflects the central bank&#8217;s data-dependent approach as trade negotiations continue and economic conditions evolve.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/topics/25/06/45714095/chamath-palihapitiya-calls-tesla-an-obvious-win-says-robotaxi-alphabets-waymo-will-overtake-uber-and-lyft">Chamath Palihapitiya Calls Tesla An &#8216;Obvious Win,&#8217; Says Robotaxi, Alphabet&#8217;s Waymo Will Overtake Uber And Lyft</a></li>
</ul>
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Photo courtesy: RozenskiP / Shutterstock.com

Federal Reserve

Fed's Christopher Waller Signals Caution On Rate Cut Amid Tariff-Driven Inflation Risks

Reported Sunday,Cenovus Energy Temporarily Halts Christina Lake Output Due To Wildfires, Affecting 238,000 BPD Of Production

<ul>
<li>– New Drug Application based on positive results from the Phase 2 KOMET-001 trial –</li>
<li>– FDA assigns a Prescription Drug User Fee Act (PDUFA) target action date of November 30, 2025 –</li>
<li>– Potential first approval of a menin inhibitor for the treatment of adult patients with relapsed or refractory AML with an NPM1 mutation –</li>
</ul>

KURA

Reported Sunday, FDA Grants Priority Review To Kura And Kyowa Kirin's Ziftomenib NDA, Targeting First Menin Inhibitor Approval In NPM1-Mutant AML By November 30

Comments

Bexil Investment Trust

Vendite allo scoperto

Bexil Investment Trust (OTC:BXSY) Azioni, Report sulle vendite allo scoperto

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO